Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 8, 2025
Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?Yavuz Katircilar, Abdulkadir Sahin, Muruvvet Seda Aydin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 25, 2024
Are mesenchymal stem cells still effective in acute GvHD management?Bahar Uncu Ulu, Ipek Yonal Hindilerden, Tugce Nur Yigenoglu, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 21, 2025
The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantationHikmetullah Batgi, Tuğba Zorlu, Mehmet Ali Erkurt, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 21, 2024
Efficacy of Ruxolitinib in the management of chronic GVHDAsli Odabasi Giden, Mehmet Ali Erkurt, Ipek Yonal Hindilerden, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 27, 2016
Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter studyMehmet Ali Erkurt, Ilhami Berber, Emre Tekgündüz, et al.
Journal of Clinical Medicine|March 14, 2026
Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from TurkeyMehmet Bakırtaş, İlhami Berber, İpek Yönal Hindilerden, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 19, 2024
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?Turgay Ulas, Sinem Namdaroglu, Ipek Yonal Hindilerden, et al.
Internal and Emergency Medicine|June 10, 2021
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancersSemih Başcı, Naim Ata, Fevzi Altuntaş, et al.
Bone Marrow Transplantation|October 28, 2020
COVID-19 in hematopoietic cell transplant recipientsFevzi Altuntas, Naim Ata, Tugce Nur Yigenoglu, et al.
Turkish Journal of Medical Sciences|May 6, 2021
COVID-19 clinical course and blood groups: Turkish population-based studyMehmet Sinan Dal, Naim Ata, Fevzi Altuntaş, et al.
Pageof 10